|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
SAMARIUM (153SM) LEXIDRONAM |
V10BX02 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/150 |
05-02-1998 |
VALID
|
|
SELPERCATINIB |
L01EX22 |
IT
|
Not authorised
|
01-06-2021 |
|
|
VALID
|
|
TUCATINIB |
L01EH03 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005263 |
11-02-2021 |
VALID
|
|
CODEINE |
R05DA04 |
IT
|
II
|
30-06-2021 |
|
|
VALID
|
|
COMBINATIONS |
R05DA20 |
IT
|
Not authorised
|
30-06-2021 |
|
|
VALID
|
|
DIMEMORFAN |
R05DA11 |
IT
|
Not authorised
|
30-06-2021 |
|
|
VALID
|
|
DROPROPIZINE |
R05DB19 |
IT
|
Not subject to prescription
|
01-07-2021 |
|
22-08-2003 |
VALID
|
|
MORCLOFONE |
R05DB25 |
IT
|
Not authorised
|
02-07-2021 |
|
|
VALID
|
|
IODINE (125I) HUMAN ALBUMIN |
V09GB02 |
IT
|
Not authorised
|
08-07-2021 |
|
|
VALID
|
|
IODINE (131I) HUMAN ALBUMIN |
V09XA03 |
IT
|
Not authorised
|
09-07-2021 |
|
|
VALID
|
|
SOMAPACITAN |
H01AC07 |
IT
|
I
|
11-10-2021 |
|
|
VALID
|
|
LINCOMYCIN |
J01FF02 |
IT
|
I
|
15-10-2021 |
|
11-02-2002 |
VALID
|
|
BENRALIZUMAB |
R03DX10 |
IT
|
I
|
18-10-2021 |
|
|
VALID
|
|
COLECALCIFEROL |
A11CC05 |
IT
|
II
|
18-10-2021 |
|
|
VALID
|
|
TESTOSTERONE |
G03BA03 |
IT
|
I
|
18-10-2021 |
|
|
VALID
|
|
BEROTRALSTAT |
B06AC06 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005138 |
30-04-2021 |
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005316 |
20-08-2021 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
DUVELISIB |
L01EM04 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
ELIVALDOGENE AUTOTEMCEL |
N07XX00 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/003690 |
16-07-2021 |
VALID
|
|
EVINACUMAB |
C10AX17 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005449 |
17-06-2021 |
VALID
|
|
IDECABTAGENE VICLEUCEL |
L01XX00 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/004662 |
18-08-2021 |
VALID
|
|
LATANOPROST AND NETARSUDIL |
S01EE51 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005107 |
07-01-2021 |
VALID
|
|
ODEVIXIBAT |
A05AX05 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
PONESIMOD |
L04AE04 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
SATRALIZUMAB |
L04AC19 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
TAFASITAMAB |
L01FX12 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005436 |
26-08-2021 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
TRALOKINUMAB |
D11AH07 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005255 |
17-06-2021 |
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005124 |
18-01-2021 |
VALID
|
|
VERICIGUAT |
C01DX22 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
VOSORITIDE |
M05BX07 |
IT
|
I
|
19-10-2021 |
EMEA/H/C/005475 |
26-08-2021 |
VALID
|
|
BUTAMIRATE |
R05DB13 |
IT
|
Not subject to prescription
|
25-01-2022 |
|
|
VALID
|
|
CLOBUTINOL |
R05DB03 |
IT
|
Not authorised
|
25-01-2022 |
|
|
VALID
|
|
PIPAZETATE |
R05DB11 |
IT
|
Not authorised
|
25-01-2022 |
|
|
VALID
|
|
DARATUMUMAB |
L01FC01 |
IT
|
I
|
27-01-2022 |
EMEA/H/C/004077 |
20-05-2016 |
VALID
|
|
DINUTUXIMAB BETA |
L01FX06 |
IT
|
I
|
27-01-2022 |
|
|
VALID
|
|
ELOTUZUMAB |
L01FX08 |
IT
|
I
|
27-01-2022 |
EMEA/H/C/003967 |
11-05-2016 |
VALID
|
|
NECITUMUMAB |
L01FE03 |
IT
|
Not authorised
|
27-01-2022 |
|
|
VALID
|
|
OLARATUMAB |
L01FX10 |
IT
|
Not authorised
|
27-01-2022 |
|
|
VALID
|
|
PEMBROLIZUMAB |
L01FF02 |
IT
|
I
|
27-01-2022 |
EMEA/H/C/003820 |
17-07-2015 |
VALID
|
|
POLATUZUMAB VEDOTIN |
L01FX14 |
IT
|
I
|
27-01-2022 |
|
|
VALID
|
|
DESLORATADINE |
R06AX27 |
IT
|
II
|
02-02-2022 |
|
|
VALID
|
|
DEXIBUPROFEN |
M01AE14 |
IT
|
II + Exemption
|
28-02-2022 |
|
|
VALID
|
|
GLUCARPIDASE |
V03AF09 |
IT
|
I
|
29-03-2022 |
|
|
VALID
|
|
OPICAPONE |
N04BX04 |
IT
|
II
|
29-03-2022 |
EMEA/H/C/002790 |
24-06-2016 |
VALID
|
